These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 3958492)

  • 1. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.
    Hackett J; Tutt M; Lipscomb M; Bennett M; Koo G; Kumar V
    J Immunol; 1986 Apr; 136(8):3124-31. PubMed ID: 3958492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
    Hackett J; Bennett M; Kumar V
    J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
    Koo GC; Dumont FJ; Tutt M; Hackett J; Kumar V
    J Immunol; 1986 Dec; 137(12):3742-7. PubMed ID: 3782794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
    Savary CA; Lotzová E
    J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells.
    Puzanov IJ; Bennett M; Kumar V
    J Immunol; 1996 Nov; 157(10):4282-5. PubMed ID: 8906800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells generated from bone marrow culture.
    Koo GC; Peppard JR; Mark WH
    J Immunol; 1984 May; 132(5):2300-4. PubMed ID: 6201540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody 4H12 recognizes subsets of adherent-lymphokine activated killer cells and splenic natural killer cells from pregnant and neonatal mice.
    Linnemeyer PA; Pollack SB
    J Immunol; 1991 Jun; 146(11):3729-35. PubMed ID: 2033249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
    Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB
    J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
    Savary CA; Lotzová E
    J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
    Morelli L; Lemieux S
    J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of natural killer cell lines from murine long-term bone marrow cultures.
    Yung YP; Okumura K; Moore MA
    J Immunol; 1985 Mar; 134(3):1462-8. PubMed ID: 3968424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
    Kalland T; Alm G; Stålhandshe T
    J Immunol; 1985 Jun; 134(6):3956-61. PubMed ID: 2580900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Ly-6E.1-monoclonal-antibody-mediated augmentation of interleukin-2-dependent generation of natural killer cell activity from mouse bone marrow cells.
    Lu L; Herberman RB; DeLeo AB
    Nat Immun; 1994; 13(6):315-30. PubMed ID: 7894202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo.
    Kung SK; Miller RG
    J Immunol; 1997 Mar; 158(6):2616-26. PubMed ID: 9058794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
    Afifi MS; Bennett M; Kumar V
    Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.